Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Commercializing In-Home Supportive Technology for Dementia Caregivers
Authors not listed
University of California, Berkeley · 2022
Abstract
This study aims to develop, evaluate, and commercialize an in-home supportive technology that is designed to alleviate anxiety, burden, and loneliness in spousal and familial caregivers of individuals with Alzheimer's disease, other dementias, or mild cognitive impairment in Spanish language homes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-26 MST
Cite this
APA
Anonymous. (2022). Commercializing In-Home Supportive Technology for Dementia Caregivers. <em>University of California, Berkeley</em>. https://clinicaltrials.gov/study/NCT05159596
Vancouver
Anonymous. Commercializing In-Home Supportive Technology for Dementia Caregivers. University of California, Berkeley. 2022.
BibTeX
@misc{anon2022Commer,
title = {Commercializing In-Home Supportive Technology for Dementia Caregivers},
author = {Anonymous},
journal = {University of California, Berkeley},
year = {2022},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University of California, Berkeley 2019
Open access · US-GOV
Developing and Evaluating In-Home Supportive Technology for Dementia Caregivers
Posit Science Corporation 2004
Open access · US-GOV
Computer-Based Training for Mild Cognitive Impairment and Mild Alzheimer's Disease
Elsevier eBooks 2021
Citation only
Nonhuman primates as models for aging and Alzheimer’s disease
Journal of Experimental & Clinical Medicine 2014
Preprint · CC-BY
Epigenomics of Alzheimer's Disease
Eli Lilly and Company 2016
Open access · US-GOV
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
Florida Atlantic University 2007
Open access · US-GOV